Stocks to BUY: Brokerages Bet on Fortis, Indus Towers, Lupin for up to 22% Gains

• Brokerage firms recommend Fortis Healthcare, Indus Towers, and Lupin after Q3 results, projecting 16-22% upside.
• Fortis Healthcare: Citi gives 'Buy' with a target of Rs 1,120 (22% upside) due to strong operational performance and 17.5% revenue growth.
• Indus Towers: Citi maintains 'Buy' with a Rs 540 target (16% upside), citing Vodafone Idea debt resolution, AGR re-evaluation, and potential Bharti Airtel purchases as key triggers.
• Lupin: Citi and Jefferies rate 'Buy' with a Rs 2,540 target (16% upside) based on positive quarterly earnings and management guidance.
• Morgan Stanley gives Lupin an 'Equal-Weight' rating with a target of Rs 2,386 (9% upside).